Shlomo Sasson

Title: Shlomo Sasson: Innovator in Metabolic Health

Introduction

Shlomo Sasson is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of metabolic health through his innovative patents. With a total of 3 patents, Sasson is recognized for his work in developing novel compounds and methods aimed at treating diseases associated with metabolic syndrome.

Latest Patents

Sasson's latest patents include groundbreaking inventions such as "Bile acid-basic amino acid conjugates and uses thereof." This patent focuses on compositions and methods for treating diseases or disorders related to metabolic syndrome using conjugates of bile acids with basic amino acids or decarboxylated amino acids like agmatine. Another notable patent is directed towards "Compounds and compositions for use in augmentation of glucose." This invention outlines various compounds that can be utilized in the treatment of diabetes and related disorders, showcasing Sasson's commitment to advancing medical science.

Career Highlights

Throughout his career, Shlomo Sasson has worked with esteemed organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Diab R&D. His work in these institutions has allowed him to further his research and contribute to the scientific community.

Collaborations

Sasson has collaborated with notable colleagues such as Erol Cerasi and Arie Lev Gruzman. These partnerships have enriched his research endeavors and have played a crucial role in the development of his innovative patents.

Conclusion

Shlomo Sasson stands out as a key figure in the field of metabolic health, with his innovative patents paving the way for new treatments and therapies. His dedication to research and collaboration continues to impact the scientific community positively.